溶栓治疗心肌梗塞的价值已被肯定,而辅助治疗的价值尚未确定。作者采用随机、双盲、安慰剂对照、平行分组设计,研究消心痛(ISDN)和链激酶联合静脉滴注对心肌梗塞面积的影响,探讨溶栓同时使用其他药物 The value of thrombolytic therapy for myocardial infarction has been affirmed, and the value of adjuvant therapy has not been established. The authors used a randomized, double-blind, placebo-controlled, parallel-group design to study the effects of combination of isodonectin (ISDN) and streptokinase on myocardial infarct size and to explore the use of other drugs